Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Off-Label Promoter In Chief: President Trump Pushes COVID-19 Therapy

24 Mar 2020

• By Michael McCaughan

Trump_Donald_160716_1200x675

Related Content

As Chloroquine Demand Surges, Bayer Looks To Emergency Use Authorization To Enter US Market

23 Mar 2020

White House Hypes Chloroquine, A Drug Currently In Shortage, As Coronavirus Treatment Hope

20 Mar 2020

Inside The COVID-19 Pipeline

20 Mar 2020

Coronavirus Product Communications Would Get Safe Harbor Under Senate Bill

22 Mar 2020

Related Companies

Bayer AG

Novartis AG

Gilead Sciences, Inc.

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Coronavirus COVID-19 Leadership Policy Politics Drug Approval Standards BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.